BioRem Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was CAD 5.51 million compared to CAD 7.31 million a year ago. Net income was CAD 0.503093 million compared to CAD 0.761179 million a year ago. Basic earnings per share from continuing operations was CAD 0.03 compared to CAD 0.05 a year ago. Diluted earnings per share from continuing operations was CAD 0.03 compared to CAD 0.04 a year ago.
For the nine months, sales was CAD 12.96 million compared to CAD 17.95 million a year ago. Net loss was CAD 0.147123 million compared to net income of CAD 0.825199 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to basic earnings per share from continuing operations of CAD 0.05 a year ago. Diluted loss per share from continuing operations was CAD 0.01 compared to diluted earnings per share from continuing operations of CAD 0.04 a year ago.